Geode Capital Management LLC Cuts Position in National Research Corporation $NRC

Geode Capital Management LLC decreased its position in National Research Corporation (NASDAQ:NRC) by 9.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 404,298 shares of the company’s stock after selling 42,275 shares during the quarter. Geode Capital Management LLC owned 1.77% of National Research worth $6,793,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. QV Investors Inc. increased its position in National Research by 7.6% in the second quarter. QV Investors Inc. now owns 381,310 shares of the company’s stock worth $6,406,000 after purchasing an additional 26,950 shares during the last quarter. AQR Capital Management LLC grew its stake in shares of National Research by 168.6% in the 1st quarter. AQR Capital Management LLC now owns 108,134 shares of the company’s stock worth $1,384,000 after buying an additional 67,882 shares in the last quarter. Jane Street Group LLC grew its stake in shares of National Research by 394.2% in the 1st quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock worth $671,000 after buying an additional 41,806 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of National Research by 7.3% in the 1st quarter. American Century Companies Inc. now owns 42,102 shares of the company’s stock worth $539,000 after buying an additional 2,848 shares during the last quarter. Finally, Nuveen LLC purchased a new stake in shares of National Research during the 1st quarter valued at about $502,000. 47.26% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of National Research in a research report on Monday. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

National Research Trading Down 2.8%

Shares of NRC opened at $15.87 on Friday. The company’s fifty day simple moving average is $14.00 and its 200-day simple moving average is $14.75. The company has a market cap of $359.61 million, a P/E ratio of 22.67 and a beta of 0.45. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 5.31. National Research Corporation has a twelve month low of $9.76 and a twelve month high of $19.71.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Monday, October 27th. The company reported $0.23 earnings per share for the quarter. National Research had a return on equity of 98.26% and a net margin of 11.76%.The firm had revenue of $34.61 million for the quarter.

National Research Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 9th. Investors of record on Friday, December 26th will be issued a $0.16 dividend. The ex-dividend date is Friday, December 26th. This is an increase from National Research’s previous quarterly dividend of $0.12. This represents a $0.64 annualized dividend and a dividend yield of 4.0%. National Research’s dividend payout ratio is presently 68.57%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.